DPLS Security Details Share Structure Market Value1...........$802,228 a/o Oct 22, 2020 Authorized Shares..20,000,000,000 a/o Oct 20, 2020 Outstanding Shares..4,011,139,156 a/o Oct 20, 2020 Restricted...............31,894,998 a/o Oct 20, 2020 Unrestricted..........3,979,244,158 a/o Oct 20, 2020 Held at DTC...............Not Available Float.....................Not Available Par Value 0.01
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18